ARMONK, New York – International Business Machines Corporation (NYSE:IBM) has seen its stock surge 14.53% since the company reported its second-quarter earnings in July, closing Friday at $235.68. The shares are now trading just 3.92% below the average price target set by Wall Street analysts, suggesting that the initial phase of the post-earnings rerating may be coming to a close.
The rally has been supported by a mixed but encouraging earnings report. In the second quarter, IBM reported total revenue of $17.16 billion, up 1% year-over-year. Software revenue grew 5% to $7.76 billion, driven by an 11% increase in Red Hat sales. However, infrastructure revenue declined 7% to $3.84 billion, largely due to a 42% drop in IBM Z revenue. Consulting revenue remained flat at $5.33 billion.
Adjusted diluted earnings per share rose 5% to $2.93, while free cash flow fell by $0.3 billion to $2.5 billion. Management continues to guide for constant-currency revenue growth of 4% to 5% for 2026 and anticipates generating approximately $1 billion in additional free cash flow compared to the prior year.
Market Performance and Sector Context
On Friday, August 21, IBM shares gained 0.85%, outperforming the S&P 500's 0.43% advance but lagging behind services peers Accenture (NYSE:ACN), which rose 2.17%, and Cognizant (NASDAQ:CTSH), which climbed 1.56%. The Dow Jones Industrial Average added 0.98%. This pattern suggests the move is part of broader sector momentum rather than a company-specific catalyst.
Over the five trading days ending August 21, IBM advanced 0.58%, with daily closes ranging from $228.85 to $237.16. Trading volume fluctuated between 3.8 million and 6.84 million shares.
Analyst Outlook and Valuation
The consensus price target for IBM stands at $244.91 (median $245), based on 25 analyst forecasts. Targets range from a low of $174 to a high of $350, reflecting a wide divergence in expectations for the company's growth resilience. The consensus rating is “Buy,” with 13 analysts rating it Strong Buy or Buy, 10 Hold, and 2 Sell or Strong Sell.
“The easy part of the rerating is likely over,” said one market strategist. “Investors now need to see sustained cash flow growth to justify further upside, especially with the infrastructure segment still under pressure.”
Quantum Breakthrough Adds Long-Term Potential
On Wednesday, IBM announced a significant milestone in its quantum computing efforts: successfully linking and cooling two modular cryogenic systems at under 15 millikelvin. The company described this as a step toward building a system with at least 1,000 programmable qubits by 2027. Jay Gambetta, head of IBM Research, called the achievement “a leap forward.” While this development could reinforce IBM's technological leadership, it does not immediately address the company's quarterly revenue mix.
Key Levels to Watch
In the coming week, investors will be watching whether IBM can hold above the $233 support level. Tracking software demand and any signs that consulting growth can resume will be critical. Risks to the upside include accelerated software expansion or quantum breakthroughs, while downside risks include soft consulting demand, continued infrastructure weakness, or higher debt from acquisitions.
IBM's stock remains a focus for investors seeking exposure to enterprise technology, but the near-term path will depend on execution across its diversified portfolio.
